SEC Filings

8-K
KALA PHARMACEUTICALS, INC. filed this Form 8-K on 01/05/2018
Entire Document
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

KALA PHARMACEUTICALS, INC.

 

 

Date: January 5, 2018

By:

/s/ Mary Reumuth

 

 

Name: Mary Reumuth

 

 

Title: Chief Financial Officer

 

3